Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates.
about
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical usePathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Human Immunodeficiency Virus (HIV).[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA.Managing haemophilia for life: 4th Haemophilia Global Summit.
P2860
Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pathogen inactivation and remo ...... clotting factor concentrates.
@en
type
label
Pathogen inactivation and remo ...... clotting factor concentrates.
@en
prefLabel
Pathogen inactivation and remo ...... clotting factor concentrates.
@en
P2093
P2860
P356
P1433
P1476
Pathogen inactivation and remo ...... clotting factor concentrates.
@en
P2093
Albrecht Gröner
Robert Klamroth
Toby L Simon
P2860
P304
P356
10.1111/TRF.12423
P577
2013-09-30T00:00:00Z